Monday, 16 December 2019

Drug Discovery News

  • Daiichi to aid drug discovery projects

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 12 Mar, 2013

    Singapore: Daiichi Sankyo has launched TaNeDS (Take a New challenge for Drug diScovery) collaborative drug discovery project for 2013. The company will select research partners for the proj...Read more

  • Queensland to get a new drug development center

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jun, 2015

    Singapore: At the recent international BIO Conference in Philadelphia, Queensland's Premier Ms Annastacia Palaszczuk announced the establishment of the University of Queensland Emory Drug D...Read more

  • FDA follows EU, declares Patrys drug as 'orphan'

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Nov, 2013

    Singapore: Australia-based Patrys, a clinical stage biotechnology company, has received confirmation of Orphan Medicinal Product Designation for its lead anti-cancer product PAT-SM6, from t...Read more

  • AbbVie, Galapagos to make drugs for cystic fibrosis mutations

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Sep, 2013

    Singapore: Europe-based Galapagos and AbbVie entered into a global alliance to discover, develop and commercialize novel potentiator and combination therapies in cystic fibrosis (CF), an in...Read more

  • Mylan to produce generic of Gilead's HIV drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Aug, 2012

    Singapore: Mylan signed a new agreement between its subsidiary Mylan Laboratories and Gilead Sciences. According top this agreement, Mylan licensed the rights to produce and market generic ...Read more

  • MNCs bet on China to tide over patent cliff

    Drug Discovery |  Analysis | By BioSpectrum Bureau  | 0 Comment | 16 May, 2012

    Even as most emerging economies in Asia Pacific are trying to grab a foothold in the global biopharma space, China has etched an important spot for itself in that space in recent times. In ...Read more

  • Anaphore changes corporate name to RuiYi

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Oct, 2012

    Singapore: Anaphore changed its corporate name to RuiYi. As part of the company's shift in strategy to the R&D of novel biologic therapies in China, including monoclonal antibodies tha...Read more

  • Phylogica gets $400K grant to boost drug discovery

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 22 Jul, 2013

    Singapore: Australia's peptide drug discovery company, Phylogica has received linkage grant from Australian Research Council (ARC) to collaborate with scientists at University of Queensland...Read more

  • Daiichi gets positive results in prasugrel trial

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 18 Mar, 2013

    Singapore: Japanese company Daiichi Sankyo has received positive results for a double-blind randomized phase III trial comparing efficacy and safety of prasugrel hydrochloride 20 mg loading...Read more

  • AstraZeneca acquires Pearl Therapeutics

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jul, 2013

    Singapore: AstraZeneca has completed its acquisition of Pearl Therapeutics, a privately held company based in Redwood City, California, focused on the development of inhaled small-molecule ...Read more

  • Target for potent first-strike influenza drugs identified

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Aug, 2012

    Singapore: Scientists at St. Jude Children's Research Hospital have reported details of how certain drugs can precisely target and inhibit an enzyme essential for the influenza virus replic...Read more

  • TaiGen gets TFDA nod for bacterial pneumonia drug

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 18 Mar, 2014

    Singapore: Taiwan based TaiGen Biotechnology has recieved Taiwan Food and Drug Administration (TFDA) approval for new drug application (NDA) of Taigexyn (nemonoxacin) oral formulation (500 ...Read more

  • Bionomics to raise $16.4 mn for Alzheimer's R&D

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Mar, 2013

    Singapore: Bionomics plans to raise up to approximately $16.4 million of funds to advance development programs across drug pipeline, including BNC375, Bionomics' drug candidate for the tre...Read more

  • Advinus gets $36 mn research funding from Takeda

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Oct, 2012

    Singapore: Takeda Pharmaceutical and Advinus Therapeutics jointly announced that they would be initiating a three-year discovery collaboration. Under the terms of the agreement, Takeda will...Read more

  • Aslan gastric cancer phase II study shows +ve results

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 28 May, 2013

    Singapore: Aslan Pharmaceuticals has revealed the results of its phase II clinical trial with Aslan001, a small-molecule pan-HER inhibitor, in gastric cancer. Aslan001 reduced cell prolifer...Read more

  • Sanofi, Regeneron cancer drug Zaltrap gets EU nod

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Feb, 2013

    Singapore: European Commission has granted marketing authorization for Sanofi and Regeneron Pharmaceuticals (EC)'s Zaltrap 25mg/ml concentrate in the European Union. Zaltrap 25mg/ml solutio...Read more

  • Low R&D output, patent cliffs drives big pharma nuts

    Drug Discovery |  Analysis | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2012

    Singapore: According to the latest global report from industry experts, GBI Research, low R&D productivity, combined with the patent cliff and a stringent US FDA approval process, is re...Read more

  • Bayer, Compugen enter $500 mn cancer deal

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2013

    Singapore: Israel-based Compugen and global pharmaceutical company Bayer are to jointly pursue a preclinical research program for research, development, and commercialization of antibody-ba...Read more



Podcast

 

Survey Box

Is APAC region emerging as a leader in assistive technologies?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls